NurExone Biologic Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	62	44	14	17	-
Market Cap Growth	60.63%	208.80%	-14.84%	-	-
Enterprise Value	60	41	13	12	-
Last Close Price	0.75	0.62	0.29	0.39	-
PB Ratio	29.62	17.35	57.03	5.89	-
P/TBV Ratio	29.62	17.35	57.03	5.89	-
Debt / Equity Ratio	0.06	0.02	6.44	0.01	0.89
Quick Ratio	1.30	2.08	0.34	4.17	1.67
Current Ratio	1.94	4.11	1.04	4.46	1.74
Return on Equity (ROE)	-307.77%	-517.23%	-318.51%	-499.17%	-
Return on Assets (ROA)	-127.74%	-135.79%	-92.09%	-123.02%	-
Return on Capital (ROIC)	-186.21%	-195.66%	-129.79%	-159.74%	-
Earnings Yield	-13.93%	-16.51%	-33.76%	-66.15%	-
FCF Yield	-10.99%	-18.13%	-28.40%	-31.58%	-
Buyback Yield / Dilution	-34.51%	-46.27%	-18.52%	-129.35%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.